Your browser doesn't support javascript.
loading
Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer.
Yang, Tao; Liu, Ying; Chen, Shuzhen; Tian, Jiale; Zhu, Xuyou; Zhang, Long; Wang, Wei; Qin, Yingyi; Richter, Jens; Anand, Aseem; Xu, Chengdang; Chi, Yongnan; Wang, Chenyang; Bian, Cuidong; Wu, Denglong; Li, Zhenfei; Huang, Shengsong.
Afiliación
  • Yang T; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Liu Y; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Chen S; Department of Nuclear Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Tian J; Department of Laboratory Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Zhu X; Department of Pathology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Zhang L; Department of Pathology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Wang W; Department of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Qin Y; Department of Health Statistics, Naval Medical University, Shanghai, China.
  • Richter J; Department of Digital Imaging Biomarkers, EXINI Diagnostics AB, Lund, Sweden.
  • Anand A; Department of Digital Imaging Biomarkers, EXINI Diagnostics AB, Lund, Sweden.
  • Xu C; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Chi Y; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Wang C; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Bian C; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Wu D; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Li Z; Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Huang S; State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
Prostate ; 82(13): 1284-1292, 2022 09.
Article en En | MEDLINE | ID: mdl-35747943
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos